verapamil has been researched along with Colitis, Granulomatous in 2 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The systems information gathered on intestine, liver and blood proteins and other physiological parameters was incorporated into a physiologically based pharmacokinetic (PBPK) platform to create a virtual population of CD patients, with a view for guiding dose adjustment in the absence of clinical data in CD." | 2.82 | Altered Bioavailability and Pharmacokinetics in Crohn's Disease: Capturing Systems Parameters for PBPK to Assist with Predicting the Fate of Orally Administered Drugs. ( Alrubia, S; Barber, J; Chen, Y; Mao, J; Rostami-Hodjegan, A, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alrubia, S | 1 |
| Mao, J | 1 |
| Chen, Y | 1 |
| Barber, J | 1 |
| Rostami-Hodjegan, A | 1 |
| Sanaee, F | 1 |
| Clements, JD | 1 |
| Waugh, AW | 1 |
| Fedorak, RN | 1 |
| Lewanczuk, R | 1 |
| Jamali, F | 1 |
1 review available for verapamil and Colitis, Granulomatous
| Article | Year |
|---|---|
Altered Bioavailability and Pharmacokinetics in Crohn's Disease: Capturing Systems Parameters for PBPK to Assist with Predicting the Fate of Orally Administered Drugs.
Topics: Administration, Oral; ATP Binding Cassette Transporter, Subfamily B; Biological Availability; Crohn | 2022 |
1 other study available for verapamil and Colitis, Granulomatous
| Article | Year |
|---|---|
Drug-disease interaction: Crohn's disease elevates verapamil plasma concentrations but reduces response to the drug proportional to disease activity.
Topics: Adolescent; Adult; Area Under Curve; Calcium Channel Blockers; Case-Control Studies; Crohn Disease; | 2011 |